Senti Biosciences Holdings, Inc. (SNTI)

Every figure this model derived for SNTI, the value it took, and the element in the company's own XBRL it was read from — so any of it can be checked against the filing rather than taken on trust. As at 2025-12-31.

The figures, and where each came from

This is the part no other screener shows. Each figure below names the XBRL element it was read from, so it can be checked against the filing itself.

FigureValueXBRL tagAs at
capex 196,000 PaymentsToAcquirePropertyPlantAndEquipment 2025-12-31
cash 6,463,000 CashAndCashEquivalentsAtCarryingValue 2026-06-30
current assets 13,007,000 AssetsCurrent 2026-06-30
current liabilities 15,765,000 LiabilitiesCurrent 2026-06-30
equity -3,401,000 StockholdersEquity 2026-06-30
ocf -38,051,000 NetCashProvidedByUsedInOperatingActivities 2026-06-30
revenue 22,000 RevenueFromContractWithCustomerExcludingAssessedTax 2025-12-31
sbc 5,339,000 ShareBasedCompensation 2026-06-30

The ratios

The figures themselves rather than their scores — what somebody looking up SNTI on one particular measure came for.

RatioValue
current ratio0.83
current ratio reported0.83
dilution pct389.73

What to be careful about

What this model itself distrusts about SNTI's figures. Written by the derivation as it ran, not added afterwards.